There is no doubt that all too many times in the past we have heard great news on non-injectable insulin drugs. First we had inhaled, which flopped and buccal which seems to be stuck in other countries except the U.S. Over the past 10 years we have had over 30 …
Read More »Letter from the Editor #721:
This past Friday I had the pleasure of presenting a CE program at the annual meeting of the Washington Association of Diabetes Educators. There were 250+ diabetes educators in attendance and we were talking about the use of new technology. During the program I asked those in the room about …
Read More »Special Edition SGLT-2 Inhibitors, March 2014
Typically when we have discussions about new drugs or drug classes they are not really discussions but presentations by someone on behalf of the manufacturer, and most of the questions are geared to promote the positive aspects of the new medication. In this month’s special edition covering SGLT-2 inhibitors, we …
Read More »Editor’s Note, DCMS #180: Adisopathy & Obesity
We know that obesity can lead to diabetes and often we focus on that in prediabetes, but as soon as someone is diagnosed with diabetes we change our focus to treating diabetes, and "live" with the obesity and weight gain. This week, in the final slides of this series by Dr. …
Read More »Letter from the Editor #720: CMS Backs MTM Services
On Thursday night I had the chance to talk to a group of MTM pharmacists for one of the original pioneer ACO’s in the U.S. It was interesting that they had been able to build a good working relationship with the prescribers in their multiple offices. Usually when I speak with …
Read More »Editor’s Note, DCMS #179
My dad has been visiting us for the past several months as he escapes the cold weather in Kentucky. Like many of our older patients he has some health challenges that could prevent him from getting enough physical activity. These frustrations are compounded by the fact that our good weather …
Read More »Letter from the Editor #719
We often talk about the increase in AGEs (Advanced Glycation Endproducts) in patients with diabetes. We mainly think about these AGE’s in the development of vascular injury in our diabetes patients. However, the collagen in our joints is also subject to glycosylation and this means that many of our diabetes …
Read More »Editor’s Desk, DCMS #178: Dangers of Grocery Store Checkout Line Magazine Browsing
I was in the check-out lane at a grocery store yesterday and, as I was waiting, I couldn’t avoid noticing the headlines of the magazines available for impulse purchase. It seemed that every one of these had some way to "cure" obesity, diabetes or even prediabetes. I glanced over three …
Read More »Letter from the Editor #718
This week I saw patients in a couple of offices and whenever the men were over 60 and had either loss of muscle or increased fat, my first thought was to get a testosterone level to find out if they were low. This got me thinking about why we make …
Read More »Editor’s Note, DCMS #177: Taking Advantage of Free Tech
We talk about the use of technology to improve diabetes care but often it is some "new magic" device that costs a fortune and that no insurance company will pay for. This week, our Disaster Averted shows how taking advantage of free technology like Skype can help you see exactly what …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.